Umbilical cord/placenta-derived mesenchymal stem cells for myelodysplastic syndrome

The aim of this study is to evaluate the safety and efficacy of administration of mesenchymal stem cells (MSCs) derived from human umbilical cord/placenta to myelodysplastic syndrome (MDS) patients.